Sectors

AAPG
Ascentage Pharma Group International
19.40
2 x 13.72
2 x 25.47
bid
ask
+
0.30
1.57%
11:15 AM
timesize
Ytd-26.07%
1y-50.75%
19.14
day range
19.40
16.36
52 week range
48.45
Open19.31Prev Close19.10Low19.14High19.40Mkt Cap1.78B
Vol5.16KAvg Vol11.47KEPS-1.61P/E-11.83Forward P/E-16.78
Beta0.09Short Ratio8.42Inst. Own0.05%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning03-2550-d Avg18.78200-d Avg25.671yr Est47.56

AAPG News

How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23%
zacks.com
How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Stree

The consensus price target hints at a 152.2% upside potential for Ascentage Pharma Group Internation

ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
benzinga.com
ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures down, Nasdaq 100 futures drop over 1%. ON Semi to acquire Synaptics, ON shares fa

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress
globenewswire.com
Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

ROCKVILLE, Md. and SUZHOU, China, June 14, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internati

Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
globenewswire.com
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
globenewswire.com
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
globenewswire.com
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatri

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026
globenewswire.com
Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 21, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress
globenewswire.com
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress

ROCKVILLE, Md. and SUZHOU, China, May 12, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma to Participate in Three Upcoming Investor Conferences
globenewswire.com
Ascentage Pharma to Participate in Three Upcoming Investor Conferences

ROCKVILLE, Md. and SUZHOU, China, May 12, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internatio

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Receives Consensus Recommendation of “Buy” from Analysts
defenseworld.net
Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Receives Consensus Recommendati

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ: AAPG - Get Free Report) has received

Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026
globenewswire.com
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at

ROCKVILLE, Md. and SUZHOU, China, April 21, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internat

Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting
globenewswire.com
Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combin

ROCKVILLE, Md. and SUZHOU, China, April 19, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internat

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Short Interest Update
defenseworld.net
Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Short Interest Update

Ascentage Pharma Group International - Unsponsored ADR (NASDAQ: AAPG - Get Free Report) was the reci

Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Sessio

U.S. stock futures lower on Thursday with Applied Digital Corp. (APLD) falling sharply in pre-market

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 result

Ascentage Pharma Group International (AAPG) Q4 2025 Earnings Call Transcript
seekingalpha.com
Ascentage Pharma Group International (AAPG) Q4 2025 Earnings Call Transcript

Ascentage Pharma Group International (AAPG) Q4 2025 Earnings Call Transcript

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
globenewswire.com
Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

ROCKVILLE, Md. and SUZHOU, China, March 25, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internat

Earnings Scheduled For March 25, 2026
benzinga.com
Earnings Scheduled For March 25, 2026

Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026
globenewswire.com
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at America

ROCKVILLE, Md. and SUZHOU, China, March 17, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group Internat

Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Hig

This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
benzinga.com
This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday
benzinga.com
This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday

benzinga.com
Earnings Scheduled For August 20, 2025